Estrogenic effects of the synthetic aminoestrogen 17β-(5-hydroxy- 1pentylamino)- 1,3,5(10)-estratrien-3-ol (pentolame)

Steroids

Volumn 63, Issue 7-8, 1998, Pages 433-438

  Lemus, Ana E ^a   Jaimez, Ruth ^a   Lemini, Cristina ^a   Menjivar, Martha ^a   Silva, Griselda ^a   Rubio Poo, Consuelo ^a   Valenzuela, Fermín ^a   Larrea, Fernando ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Aminoestrogens; Blood coagulation; Estrogens; Neuroendocrine effects; Steroids

Indexed keywords

ESTROGEN DERIVATIVE; LUTEINIZING HORMONE; PENTOLAME; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DOSE RESPONSE; DRUG DESIGN; DRUG EFFECT; DRUG STRUCTURE; ENDOMETRIUM CYTOLOGY; ESTROGEN ACTIVITY; ESTROGEN RELEASE; FEMALE; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; RAT; RECEPTOR DENSITY; UTERUS WEIGHT;

AMINO ALCOHOLS; ANIMALS; BLOOD COAGULATION; ESTRADIOL CONGENERS; ESTRENES; FEMALE; INJECTIONS, SUBCUTANEOUS; LUTEINIZING HORMONE; ORGAN SIZE; OVARIECTOMY; PITUITARY GLAND, ANTERIOR; RATS; RATS, WISTAR; RECEPTORS, PROGESTERONE; UTERUS;

EID: 0031842890     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(98)00046-4     Document Type: Article

References (17)

1. Fernández-G J.M., Rubio-Arroyo M.F., Soriano-García M., Toscano R.A., Pérez-César M.C., Rubio-Póo C., Mandoki J.J., de la Peña A., Lemini C., Mendoza-Patiño N., Cruz F. Synthesis and molecular structure of prolame, N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-3-hydroxypropylamine; an amino-estrogen with prolonged anticoagulant and brief estrogenic effects. Steroids. 45:1985;151-157.
2. Lemini C., Rubio-Póo C., Silva G., García-Mondragon J., Zavala E., Mendoza-Patiño N., Castro D., Cruz-Almanza R., Mandoki J.J. Anticoagulant and estrogenic effects of two new 17β-aminoestrogens, butolame [17β-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17β-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol]. Steroids. 58:1993;457-461.
3. Rubio-Póo C., Mandoki J.J., Mendoza-Patiño N., Lemini C., de la Peña A., Cruz F., Zavala E., Silva G., Mondragón-García J., Fernández-G J.M., Soriano-García M., Toscano A.R. The anticoagulant effect of prolame, N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-3-hydroxypropylamina, a novel amino-estrogen. Steroids. 45:1985;159-170.
4. Rubio-Póo Lemini C., García-Mondragón J., de la Peña A., Jayme V., Mendoza-Patiño N., Zavala E., Silva G., Blickenstaff R.T., Fernández-G J.M., Mandoki J.J. The anticoagulant effect of hexolame, N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl]-6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect. Steroids. 55:1990;83-86.
5. Mandoki J.J., Rubio-Póo C., Lemini C., De la Peña A., Fernández-G J.M., García-Mondragon J., Zavala E., Silva G., Mendoza-Patiño N. The effects of five new 17β-amino-estrogens, buoame, endiame, etolame, picae, and procame on blood clotting time. Proc West Pharmacol Soc. 34:1991;99-106.
6. De la Peña A., Baños G., Izaguirre R., Mandoki J.J., Fernández-G J.M. Comparative effects of synthetic aminoestrogens with estradiol on platelet aggregation. Steroids. 58:1993;407-409.
7. De la Peña A., Baños G., Izaguirre R., Tobón-Cervantes A., Fernández-G J.M. Comparative effect of three synthetic alkanol-amino-estrogens; etolame, buolame and pentolame on platelet aggregation. Med Sci Res. 22:1994;119-120.
8. Larrea F., Moctezuma O., Pérez-Palacios G. Estrogen-like effects of norethisterone on the hypothalamic pituitary unit of ovariectomized rats. J Steroid Biochem. 20:1984;841-847.
9. Vilchis F., Chávez B., Pérez A.E., García G.A., Angeles A., Pérez-Palacios G. Evidence that a non-aromatizable metabolite of norethisterone induces estrogen-dependent pituitary progestin receptors. J Steroid Biochem. 24:1986;525-531.
10. Chávez B., Vilchis F., Pérez A.E., García G.A., Grillasca P. I, érez-Palacios G. Stereospecificity of the intracellular binding of norethisterone and its A-ring reduced metabolites. J Steroid Biochem. 22:1985;121-126.
11. Larrea F., Oliart R.M., Granados J., Mutchinick O., Díaz-Sánchez V., Musto N.A. Genetic polymorphism of the human sex hormone-binding globulin evidence of an isolectric focusing variant with normal androgen-binding affinities . J Steroid Biochem. 36:1990;541-548.
12. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem. 72:1976;248-254.
13. Zar J.H. Multiple comparisons. Kurtz B. Biostatistical Analysis. 1984;176-205 Prentice-Hall, New Jersey.
14. Jayme V., Rubio-Póo C., Mandoki J.J., Lemini C. Effects of chronic administration of two 17β-aminoestrogens, butolame and pentolame, on the reproductive male tract of the rat. Med Sci Res. 22:1994;421-422.
15. Halchmi S., Marden E., Martin G., MacKay H., Abbondanza C., Brown M. Estrogen receptor-associated proteins possible mediators of hormone-induced transcription . Science (Washington, DC). 264:1994;1455-1458.
16. McDonnell D.P., Dana S., Hoener P., Lieberman B., Imhof M., Stein R. Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor. Ann NY Acad Sci. 761:1995;121-137.
17. McDonnell D.P., Clevenger B., Dana S., Santiso-Mere D., Tzukerman M.T., Gleeson M.A. The mechanisms of action of steroid hormones a new twist to an old tale . J Clin Pharmacol. 33:1993;1165-1172.